SOUTHRIDGE CAPITAL MANAGEMENT LLC ADVISED FUND PROVIDES UP TO $10 MILLION THROUGH PRIVATE EQUITY AGREEMENT WITH AKERS BIOSCIENCES, INC.

Southridge Capital Management LLC, a niche investment firm that provides financing to small-cap and micro-cap companies through private placements, announces that Brittany Capital Management LTD, a fund it advises, has closed a private equity agreement which can provide up to $10 million in financing with Akers Biosciences, Inc. (LSE: AKR).

Ridgefield, CT (PRWEB) September 25, 2003 - Southridge Capital Management LLC (Southridge"), a niche investment firm that provides financing to small-cap and micro-cap companies through private placements, is pleased to announce that Brittany Capital Management LTD, a fund it advises, has closed a private equity agreement which can provide up to $10 million in financing with Akers Biosciences, Inc. (Akers") (LSE: AKR).

Akers is a global leader in health-care related diagnostic point-of-care testing. The company is listed on the Alternative Investment Market in the United Kingdom and is one of many international financings that Southridge has undertaken. Funds will be used to fulfill Akers backlog of test products resulting in improved patient treatment.

Ray Akers, Chief Executive Officer and President of Akers stated, We believe we have an exciting future in meeting the needs of health-care professionals. We look forward to a long-term relationship with Southridge and view them as a strategic partner in assisting us in meeting our business objectives."

About Southridge

Since its founding in 1996, Southridge advised funds have provided in excess of $1.0 billion in growth capital to emerging companies. Southridge is committed to funding companies with robust business models in the U.S. and Europe.

For further information please contact:

Steve Bruce / Kayt Makosy
The Abernathy MacGregor Group
T: 212-371-5999
###